The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...
BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology ...
Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...
Philip Taylor; Investor Relations; Pulse Biosciences Inc. Paul Laviolette; Co-Chairman of the Board, President, Chief Executive Officer; Pulse Biosciences Inc. Jon S ...
22h
BioAtla Inc (BCAB) reports promising clinical progress and strategic initiatives, despite facing financial constraints and operational challenges.
Eleonora Teplinsky, MD, a medical oncologist specializing in breast and gynecologic cancers, has seen unregulated and ...
Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback